These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 33988336)

  • 1. Characteristics and Donation Outcomes of Potential Organ Donors Perceived to Be at Increased Risk for Blood-borne Virus Transmission: An Australian Cohort Study 2010-2018.
    Waller KMJ; De La Mata NL; Rosales BM; Hedley JA; Kelly PJ; Thomson IK; O'Leary MJ; Cavazzoni E; Ramachandran V; Rawlinson WD; Wyburn KR; Webster AC
    Transplantation; 2022 Feb; 106(2):348-357. PubMed ID: 33988336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New blood-borne virus infections among organ transplant recipients: An Australian data-linked cohort study examining donor transmissions and other HIV, hepatitis C and hepatitis B notifications, 2000-2015.
    Waller KMJ; De La Mata NL; Hedley JA; Rosales BM; O'Leary MJ; Cavazzoni E; Ramachandran V; Rawlinson WD; Kelly PJ; Wyburn KR; Webster AC
    Transpl Infect Dis; 2020 Dec; 22(6):e13437. PubMed ID: 32767859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deceased Organ Donors With a History of Increased Risk Behavior for the Transmission of Blood-Borne Viral Infection: The UK Experience.
    Trotter PB; Summers DM; Robb M; Hulme W; Ushiro-Lumb I; Watson CJE; Neuberger J; Bradley JA
    Transplantation; 2017 Jul; 101(7):1679-1689. PubMed ID: 28291157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multicentre interventional study to assess blood-borne viral infections in Belgian prisons.
    Busschots D; Kremer C; Bielen R; Koc ÖM; Heyens L; Brixko C; Laukens P; Orlent H; Bilaey P; De Smet F; Hellemans G; Muyldermans G; Van Baelen L; Hens N; Van Vlierberghe H; Robaeys G
    BMC Infect Dis; 2021 Jul; 21(1):708. PubMed ID: 34315415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness of Kidney Transplantation From Donors at Increased Risk of Blood-borne Virus Infection Transmission.
    Shah KK; Wyld M; Hedley JA; Waller KMJ; De La Mata N; Webster AC; Morton RL
    Transplantation; 2023 Sep; 107(9):2028-2042. PubMed ID: 37211651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing Solid Organ Donors and Monitoring Transplant Recipients for Human Immunodeficiency Virus, Hepatitis B Virus, and Hepatitis C Virus Infection - U.S. Public Health Service Guideline, 2020.
    Jones JM; Kracalik I; Levi ME; Bowman JS; Berger JJ; Bixler D; Buchacz K; Moorman A; Brooks JT; Basavaraju SV
    MMWR Recomm Rep; 2020 Jun; 69(4):1-16. PubMed ID: 32584804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The risk of HIV, HBV, HCV and HTLV infection among musculoskeletal tissue donors in Australia.
    Yao F; Seed C; Farrugia A; Morgan D; Cordner S; Wood D; Zheng MH
    Am J Transplant; 2007 Dec; 7(12):2723-6. PubMed ID: 17983391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seroprevalence and demographic factors associated with hepatitis B, hepatitis C and HIV infection from a hospital emergency department testing programme, London, United Kingdom, 2015 to 2016.
    Bundle N; Balasegaram S; Parry S; Ullah S; Harris RJ; Ahmad K; Foster GR; Tong CY; Orkin C
    Euro Surveill; 2019 Jul; 24(27):. PubMed ID: 31290390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opt-out testing for blood-borne viruses in primary care: a multicentre, prospective study.
    O'Kelly M; Byrne D; Naughten E; Bergin C; Williams C
    Br J Gen Pract; 2016 Jun; 66(647):e392-6. PubMed ID: 27114211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determining the factors associated with blood-borne virus testing of substance misusers presenting to hospital.
    Tennant E; Vollmer-Conna U; Demirkol A; Post JJ
    Intern Med J; 2017 Aug; 47(8):907-914. PubMed ID: 28560729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of Blood-Borne Viruses and Predictors of Risk in Potential Organ Donors in Australia.
    Dutch MJ; Patrick CJ; Boan PA; Knott JC; Opdam HI
    Transpl Int; 2022; 35():10395. PubMed ID: 35592445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Residual risk of infection with blood-borne viruses in potential organ donors at increased risk of infection: systematic review and meta-analysis.
    Waller KM; De La Mata NL; Kelly PJ; Ramachandran V; Rawlinson WD; Wyburn KR; Webster AC
    Med J Aust; 2019 Nov; 211(9):414-420. PubMed ID: 31489635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Probability of viremia with HBV, HCV, HIV, and HTLV among tissue donors in the United States.
    Zou S; Dodd RY; Stramer SL; Strong DM;
    N Engl J Med; 2004 Aug; 351(8):751-9. PubMed ID: 15317888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Organ Donation from Donors with Hepatitis B or C in South Korea: A 2013-2017 Nationwide Data Analysis.
    Park H; Jung ES; Lee MH; Lee JM
    Ann Transplant; 2021 Apr; 26():e928947. PubMed ID: 33927178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential organ donors with primary brain tumours: missed opportunities for donation and transplantation identified in Australian cohort study 2010-2015.
    Thomson IK; Hedley J; Rosales BM; Wyburn K; O'Leary MJ; Webster AC
    ANZ J Surg; 2022 Nov; 92(11):2996-3003. PubMed ID: 36129448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using an electronic health record alert to prompt blood-borne virus testing in primary care.
    Chadwick D; Forbes G; Lawrence C; Lorrimer S; van Schaik P
    AIDS; 2021 Sep; 35(11):1845-1850. PubMed ID: 33973875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantifying the risk of undetected HIV, hepatitis B virus, or hepatitis C virus infection in Public Health Service increased risk donors.
    Jones JM; Gurbaxani BM; Asher A; Sansom S; Annambhotla P; Moorman AC; Kamili S; Brooks JT; Basavaraju SV
    Am J Transplant; 2019 Sep; 19(9):2583-2593. PubMed ID: 30980600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incorporating HIV/hepatitis B virus/hepatitis C virus combined testing into routine blood tests in nine UK Emergency Departments: the "Going Viral" campaign.
    Orkin C; Flanagan S; Wallis E; Ireland G; Dhairyawan R; Fox J; Nandwani R; O'Connell R; Lascar M; Bulman J; Reeves I; Palfreeman A; Foster GR; Ahmad K; Anderson J; Tong CY; Lattimore S
    HIV Med; 2016 Mar; 17(3):222-30. PubMed ID: 26919291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deceased organ donor screening for HIV, hepatitis B, and hepatitis C viruses: a survey of organ procurement organization practices.
    Theodoropoulos N; Jaramillo A; Ladner DP; Ison MG
    Am J Transplant; 2013 Aug; 13(8):2186-90. PubMed ID: 23711196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Excerpt from PHS guideline for reducing HIV, HBV and HCV transmission through organ transplantation.
    Seem DL; Lee I; Umscheid CA; Kuehnert MJ
    Am J Transplant; 2013 Aug; 13(8):1953-62. PubMed ID: 23890284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.